Ledger.Open graph →
SEC Form D · filed January 6, 2020

Aro Biotherapeutics Co

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Karyn B. O'Neil · Philadelphia, PAExec · DirectorElizabeth B. Anderson · Philadelphia, PADirectorBruce B. Peacock · Philadelphia, PADirectorSusan B. Dillon · Philadelphia, PAExec · DirectorMark B. Laurenzi · Philadelphia, PAExecKevin C. Smith · Denver, COExec · DirectorCharles R. Conn · Oxford, United KingdomDirectorMatthew S. Thompson · Fort Collins, CODirectorSteve S. Deitsch · Fort Collins, COExecJamie S. Haggard · Fort Collins, COExec · DirectorCraig Dickman · GREEN BAY, WIDirectorBob Vruggink · STEAMBOAT SPRINGS, COExecTyler Ellison · EGG HARBOR, WIExec · DirectorBill Butler · LOS ANGELES, CAExec · DirectorC. D. Adair · Nashville, TNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗